Abstract
Osteoporotic drugs are used to prevent fragility fractures, but their role in fracture healing still remains unknown. Thus, alternative agents with suitable mode of delivery are needed to promote fracture healing. This study was performed to investigate the effects of direct deliveries of lovastatin and tocotrienol to fracture sites on ossification-related gene expression in fracture healing in a postmenopausal osteoporosis model. Forty-eight Sprague Dawley female rats were divided into six groups. Group I comprised the sham-operated rats, while Groups II–VI were ovariectomized rats. After 8 weeks, the right tibiae of all rats were fractured and stabilized. Group I and Group II were given two single injections of lovastatin and tocotrienol carriers. Group III was given an estrogen preparation at 64.5 µg/kg daily via oral gavages. Group IV was injected with lovastatin particles (750 µg/kg), while Group V was injected with tocotrienol particles (60 mg/kg). Group VI received two single injections of 750 µg/kg lovastatin particles and 60 mg/kg tocotrienol particles. After 4 weeks, the gene expressions were measured. Group VI showed significantly higher gene expressions of osteocalcin, BMP-2, VEGF-α, and RUNX-2 compared to Group II. In conclusion, combined treatment of lovastatin and tocotrienol upregulated the expression of genes related to fracture healing.
Highlights
IntroductionOsteoporosis is a common skeletal disorder characterized by low bone mass and microarchitechural deterioration of bone tissue that predisposes patients to fragile bones and increased fracture risk [1]
Osteoporosis is a common skeletal disorder characterized by low bone mass and microarchitechural deterioration of bone tissue that predisposes patients to fragile bones and increased fracture risk [1].Bone fragility and fractures due to osteoporosis can cause severe pain, disability, and in some cases, secondary complications that can even lead to death [2]
The osteocalcin gene expression of the tibial bones was significantly higher in Group VI compared to Group II (p < 0.05)
Summary
Osteoporosis is a common skeletal disorder characterized by low bone mass and microarchitechural deterioration of bone tissue that predisposes patients to fragile bones and increased fracture risk [1]. Bone fragility and fractures due to osteoporosis can cause severe pain, disability, and in some cases, secondary complications that can even lead to death [2]. The most common diagnostic method is Dual-Energy X-ray Absorptiometry (DEXA), which has been validated in the clinical field for measuring bone density. DEXA is not suitable as a gold standard technique and as a screening tool in primary health care level for prevention purposes due to its radiation dose and high costs. A diagnostic method that uses ultrasound such as quantitative ultrasound scanner (QUS)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Environmental Research and Public Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
